Navigation Links
Progenics and Wyeth Announce Positive Results from Three-Month,Clinical-Extension Study of Subcutaneous Methylnaltrexone for the,Treatment of Opioid-Induced Constipation in Patients with Advanced,Illness

PSMA vaccine in phase 1 clinical testing. The Company also is developing a cancer vaccine, GMK, in phase 3 clinical trials for the treatment of malignant melanoma.

PROGENICS DISCLOSURE NOTICE: The information contained in this document is current as of June 28, 2007. This press release contains forward-looking statements. Any statements contained herein that are not statements of historical fact may be forward-looking statements. When the Company uses the words "anticipates," "plans," "expects" and similar expressions, it is identifying forward-looking statements. Such forward-looking statements involve risks and uncertainties which may cause the Company's actual results, performance or achievements to be materially different from those expressed or implied by forward-looking statements. Such factors include, among others, the uncertainties associated with product development, the risk that clinical trials will not commence or proceed as planned, the risks and uncertainties associated with dependence upon the actions of our corporate, academic and other collaborators and of government regulatory agencies, the risk that our licenses to intellectual property may be terminated because of our failure to have satisfied performance milestones, the risk that products that appear promising in early clinical trials do not demonstrate efficacy in larger-scale clinical trials, the risk that we may not be able to manufacture commercial quantities of our products, the uncertainty of future profitability and other factors set forth more fully in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2006, and other reports filed with the Securities and Exchange Commission, to which investors are referred for further information. In particular, the Company cannot assure you that any of its programs will result in a commercial product.

Progenics does not have a policy of updating or revising forward-looking statements and assumes no obligation
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Progenics Announces Positive Results in Clinical Trial of Novel HIV Therapy
2. Wyeth Presents Phase 3 Data for Pristiq, an Investigational Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
(Date:5/22/2013)... 22, 2013 /PRNewswire-iReach/ -- MarketReportsOnline.com announces addition of ... Series (4) 2013 Edition Material and Clinical Trial ... Registration: A Guidebook of Registration Application for Imported ... its online database. The traditional medicines ... always regarded by occidental as mysterious medicines. Until ...
(Date:5/22/2013)... 22, 2013 Assured Pharmacy, Inc. (APHY), a ... to sufferers of chronic pain, announced it has engaged ... relations firm, to raise its visibility and strengthen its ... past year, we have proven our business model and ... to open two additional new pharmacies in ...
(Date:5/22/2013)... TEL AVIV, Israel , May 22, 2013 /PRNewswire/ ... "Company") (TASE, NASDAQ: EMITF) announced today, further to the ... filed a motion with the Tel Aviv ... of its unsecured creditors and shareholders for the approval ... debt pursuant to a plan of arrangement (the "Arrangement") ...
Breaking Medicine Technology:China Pharmaceutical Market Guidebook Series (4) 2013 Report 2China Pharmaceutical Market Guidebook Series (4) 2013 Report 3China Pharmaceutical Market Guidebook Series (4) 2013 Report 4China Pharmaceutical Market Guidebook Series (4) 2013 Report 5Assured Pharmacy Hires Hayden IR 2Assured Pharmacy Hires Hayden IR 3Elbit Imaging Announces the Court Decision with Respect to Filing of Plan of Arrangement with the Israeli Court 2Elbit Imaging Announces the Court Decision with Respect to Filing of Plan of Arrangement with the Israeli Court 3
... 1, 2011 CMC Biologics today announced the completion ... (2,000L SUB) at its manufacturing facility in Copenhagen. The ... Biologics has in its manufacturing facilities in Copenhagen and ... be ready for GMP contract manufacturing by December 2011. ...
... R.I., Sept. 1, 2011 The CVS Caremark Charitable ... today a donation of $75,000 to the American Red ... the east coast of the United States impacted by ... in free water, ice and other supplies to local ...
Cached Medicine Technology:CMC Biologics Adds 2,000 Liter Single-Use Bioreactor at its Copenhagen Manufacturing Facility 2CVS Caremark Charitable Trust and CVS/pharmacy Provide Over $100,000 in Disaster Relief To Communities Impacted by Hurricane Irene 2
(Date:5/22/2013)... -- Roughly four in 10 uninsured patients who have ... do not have the lung disease, a small new ... based on an evaluation of symptoms, rather than by ... as spirometry, which shows how well a patient,s lungs ... can exhale and how long that takes. ...
(Date:5/22/2013)... 2013, Paris, France: Results from a large ... question whether bivalirudin is superior to heparin ... similar 30-day mortality in patients with non-ST ... percutaneous coronary intervention (PCI)., European and US ... an alternative to unfractionated heparin plus GP ...
(Date:5/22/2013)... Seva Call (Save-A-Call) has launched in Detroit, ... connects consumers to the right available professional by phone ... handle personal matters than the national and state average ... So, they really can’t afford the 30 minutes most ... , Now, Detroit residents will be able to hear ...
(Date:5/22/2013)... LDM Global ( http://www.ldmglobal.com ) a ... law firms, corporations and government agencies announces that it ... software company, to deliver defensible ESI collections with eCloudCollect. ... Data and LDM Global hosted a VIP Happy Hour ... 21st. This event was in conjunction with LegalTech ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Many people ... looking for education on how to lose weight safely ... be challenging and may demotivate people to continue their ... study discussed this week on Medical News Today ... how to lose weight and actually losing those initial ...
Breaking Medicine News(10 mins):Health News:COPD May Be Over-Diagnosed Among Uninsured 2Health News:Registry questions superiority of bivalirudin over heparin 2Health News:Seva Call Revs Its Engines to Launch in Motor City 2Health News:LDM Global Enhances Forensic Data Collection Services with eCloudCollect 2Health News:LDM Global Enhances Forensic Data Collection Services with eCloudCollect 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Break the Cycle of Obesity and Weight Gain With New Education For Patients on How to Lose Weight the Healthy Way 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Break the Cycle of Obesity and Weight Gain With New Education For Patients on How to Lose Weight the Healthy Way 3
... sponge like particles may come to the therapeutic aid ... Brian Saunders from The School of Materials// and Professor ... Sciences. ,The tiny gel particles discovered by ... injected into the damaged region. This study was performed ...
... paucity of anesthesiologists in the province of Ontario, evident in ... tide over such a situation, Ontario has created two additional ... times for patients. This strategy has proved its weight in ... time tested measure to improve patient care. ...
... least two servings of fruits and three servings of ... Americans are not eating enough fruits and vegetables. This ... diet high in fruits and vegetables is associated with ... as cardiovascular disease, diabetes and some cancers. ...
... Organization estimates that nearly nine million people around the ... year//. The bacterium behind the notorious lung disease was ... 125th anniversary on March 24th, also The World Tuberculosis ... the disease is vanquished. ,Experts are particularly ...
... and figures has shown the dangerous increase in Type 1 ... number of children below five years of age, battling the ... 1985 and 2004. ,Type 1 diabetes or insulin ... opposed to Type 2 diabetes, which develops much later. According ...
... southern Indian state of Kerala, have said that "chance inhalation" ... of the three partying youngsters, including a girl in December last. ... a closed garage, by the side of a car parked there. ... ,The police now say that the youngsters had pulled ...
Cached Medicine News:Health News:Eat Fruits- Keep Diseases at Bay 2Health News:Eat Fruits- Keep Diseases at Bay 3Health News:Kerala Youth Die of Carbon Monoxide Inhalation 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: